Dermatology

Simpson EL, Hebert AA, Browning J, Serrao RT, Sofen H, Brown PM, Piscitelli SC, Rubenstein DS, Tallman AM. Tapinarof Improved Outcomes and Sleep for Patients[...]

By sjmartinez • January 9, 2025

Kingston P, Peterson H, Lee K, Huang MY, Yee D, Korouri E, Armstrong AW. Gender differences in pain interference with daily activities and functional impairment[...]

By sjmartinez • January 9, 2025

Wongvibulsin S, Lee I. Artificial Intelligence and Dermatology. JAMA Dermatol. 2025 Jan 8. doi: 10.1001/jamadermatol.2024.4645. Epub ahead of print. PMID: 39774621.

By sjmartinez • January 9, 2025

Blauvelt A, Kircik L, Schlesinger T, Pierce E, Burge R, Behling M, Atwater AR, ElMaraghy H, Armstrong A. Lebrikizumab is associated with improvements in patient-reported[...]

By sjmartinez • January 7, 2025

Mboning L, Costa EK, Chen J, Bouchard LS, Pellegrini M. BayesAge 2.0: a maximum likelihood algorithm to predict transcriptomic age. Geroscience. 2025 Jan 3. doi:[...]

By sjmartinez • January 4, 2025

Kakani P, Davis J. Racial/Ethnic Disparities in Cutaneous T-cell Lymphoma: A Clinical Review. Skinmed. 2024 Dec 31;22(6):422-426. PMID: 39748573.

By sjmartinez • January 3, 2025

Johri S, Jeong J, Tran BA, Schlessinger DI, Wongvibulsin S, Barnes LA, Zhou HY, Cai ZR, Van Allen EM, Kim D, Daneshjou R, Rajpurkar P.[...]

By sjmartinez • January 3, 2025

Barghi A, Noveir SD, Mainwaring W, Milani-Nejad N, Bernet L. Treatment of pembrolizumab-induced bullous pemphigoid with dupilumab: A case report and review of the literature.[...]

By sjmartinez • January 2, 2025

Sofen HL, Gebauer K, Spelman L, Yamauchi PS, Yao SL, Nishandar T, Kopeloff I, Crane M, Gogineni R, Kothekar M, Bagel J. Efficacy and Safety[...]

By sjmartinez • December 26, 2024

Burshtein J, Armstrong A, Chow M, DeBusk L, Glick B, Gottlieb AB, Gold LS, Korman NJ, Lio P, Merola J, Rosmarin D, Rosenberg A, Van[...]

By sjmartinez • December 22, 2024